Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
Results for 'Levofloxacin: Pipeline™ Developer' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Levofloxacin Pipeline Developer |
Ongoing | £3795 | 100 % |
|
Levofloxacin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 | 96 % |
|
Levofloxacin: Core Country Coverage Pipeline Selector |
Ongoing | £260 | 96 % |
|
Commercial Insight: Antibacterials Growth in resistance rates drives niche indications |
December 2006 | £8000 | 50 % |
|
Commercial Insight Antibacterials Growth in resistance rates drives niche indications |
January 2007 | £8000 | 49.5 % |
|
Daiichi Sankyo: Pipeline, Products, Performance, Potential |
June 2008 | £595 | 34.65 % |
|
Daiichi Sankyo Pipeline, Products, Performance, Potential |
October 2008 | £595 | 34.65 % |
|
Johnson & Johnson Prospects to 2010 |
June 2007 | £595 | 30.8 % |
|
Collagens Clinical Trial Analysis |
July 2009 | £635 | 30.45 % |
|
Sawai Pharmaceuticals Generics Company Intelligence Report Company Intelligence Report |
March 2009 | £195 | 21.35 % |
|
Mylan Generics Company Intelligence Report Company Intelligence Report |
March 2009 | £195 | 13.3 % |
|
Stakeholder Opinions: Skin and soft tissue infections |
July 2009 | £3800 | 13.3 % |
|
Antibiotics Global Trends |
November 2009 | £1905 | 9.1 % |
|
Stakeholder Opinions: Cystic Fibrosis - A pipeline full of hope Healthcare |
March 2009 | £2000 | 8.75 % |
|
Anti Infectives, Vol II: Antibacterials |
April 2007 | £1905 | 7.7 % |
|
Generic Competition, 2007–11 The impact of patent expiries on sales of major drugs |
February 2007 | £1375 | 7.7 % |
|
Injectable Generic Drugs Prospects & Opportunities to 2013 |
July 2008 | £1295 | 7.35 % |
|
Stakeholder Insight: Respiratory Tract Infections in the USA The demise of narrow-spectrum antibiotics |
November 2006 | £8000 | 7 % |
|
Stakeholder Insight: Respiratory Tract Infections in the USA The demise of narrow-spectrum antibiotics |
November 2006 | £8000 | 7 % |
|
Handbook of Pharmaceutical Manufacturing Formulations - Vol 1 of 6 Compressed Solid Products |
April 2007 | £195 | 5.25 % |





